New CRISPR based gene-editing treatment targets root cause of kidney disease
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in chronic kidney disease risk among...
Daniel Amante, PhD, MPHPhoto: Bryan Goodchild From patient portals and text messages to wearable devices and artificial intelligence, digital...
State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed Forces PacificArmed...
The provincial government has awarded Brock University more than $478,000 to purchase specialized equipment for four technology and health research...
Right now, about 7,000 people are awaiting a kidney transplant in the UK. According to NHS figures, in 2024/25 only...